On Monday I looked at three ASX shares that have been given buy ratings by leading brokers this week.
Unfortunately, not all shares are in favour with brokers right now. The three shares listed below have all just been given sell ratings. Here’s why they are bearish on them:
ASX Ltd (ASX: ASX)
According to a note out of Morgans, its analysts have retained their reduce rating but lifted the price target on this stock exchange operator’s shares to $72.14 following its half year results release. ASX Ltd delivered a result which was in line with the broker’s expectations. But this wasn’t enough for a change of rating. Morgans continues to believe that its shares are expensive at the current level and therefore holds firm with its reduce rating. The ASX Ltd share price is trading at $82.17 this afternoon.
Bendigo and Adelaide Bank Ltd (ASX: BEN)
A note out of the Macquarie equities desk reveals that its analysts have retained their underperform rating and trimmed the price target on this regional bank’s shares to $8.75. According to the note, the broker was pleasantly surprised by Bendigo and Adelaide Bank’s margin trends in the first half. However, it doesn’t appear confident that the trends will stay positive for long. It expects margin pressures to reappear in the second half and weigh on its performance. The Bendigo and Adelaide Bank share price is down 5% to $10.02 this afternoon.
Paradigm Biopharmaceuticals Ltd (ASX: PAR)
Another note out of Morgans reveals that its analysts have retained their reduce rating but lifted the price target on this biopharmaceutical company’s shares to $2.16. According to the note, Paradigm’s first half results were largely in line with its expectations. However, the broker continues to believe that the company’s shares are overvalued at the current level. It appears to think the market is getting ahead of itself based on inconclusive results from its phase two osteoarthritis trial. The Paradigm share price is currently changing hands notably higher than this price target at $3.99.
These 3 stocks could be the next big movers in 2020
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
*Returns as of 6/8/2020
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
- 3 mid cap ASX shares to buy for strong potential returns – September 23, 2020 4:17pm
- Why the Data#3 (ASX:DTL) share price just stormed to a record high – September 23, 2020 3:54pm
- Where to invest $10,000 into ASX shares right now – September 23, 2020 3:26pm